Generation [tmco]
Angiotensin II Type 1 Receptor Antagonists [phsu]
modulate [spco]
Peroxisome Proliferator-Activated Receptor gamma [aapp, rcpt]
Discovery [acty]
anti hypertensive [phsu]
Angiotensin Receptor Blockers [phsu]
Type I [clas]
telmisartan [orch, phsu]
irbesartan [orch, phsu]
Capability [qlco]
activating [acty]
Activated [acty]
receptor [aapp, rcpt]
Gamma [npop]
Provided [acty]
Novel [tmco]
Approach [spco]
Generation [tmco]
metabolic effects [phsf]
Blocking [mobd]
angiotensin II-mediated signaling pathway [moft]
Pro [aapp, bacs]
Inflammatory [ftcn]
Type I [clas]
receptor [aapp, rcpt]
activating [acty]
Activated [acty]
receptor [aapp, rcpt]
Gamma [npop]
Dependent [qlco]
Anti-inflammatory [phsu]
Pathway [moft]
Compound [qlco]
Broad [spco]
Anti-inflammatory [phsu]
Protection [fndg]
Compared [acty]
i e [diap, inpr]
Lacking [qlco]
Activated [acty]
receptor activity [moft]
Gamma [npop]
telmisartan [orch, phsu]
irbesartan [orch, phsu]
function [phsf]
Activated [acty]
receptor [aapp, rcpt]
Gamma [npop]
Modulator [mnob]
effects [qlco]
Blood Pressure [orgf]
reduction [npop]
INCREASED SENSITIVITY [phpr]
Insulin [aapp, horm, phsu]
Improved [qlco]
Lipid [lipd]
Profile [lbpr]
Improved [qlco]
Anti-inflammatory [phsu]
Atherogenesis [patf]
Profile [lbpr]
properties [qlco]
Superior [spco]
Efficacy [qlco]
hypertensive [fndg]
Patients [podg]
Insulin [aapp, horm, phsu]
Resistant [ftcn]
State [geoa]
Metabolic syndrome [dsyn]
Type 2 Diabetes [dsyn]
exiting [spco]
telmisartan [orch, phsu]
irbesartan [orch, phsu]
Added [ftcn]
Benefits [qnco]
treatment [ftcn]
Cardiovascular Diseases [dsyn]
Metabolic [ftcn]
Pathology [bmod]
End [spco]
Organ [bpoc]
Microvascular [ftcn]
Complications [patf]
Unique [qlco]
Subset [clas]
strategies [menp]
Platform [resd]
Class [inpr]
Activated [acty]
receptor ligand [moft]
Gamma [npop]
Capability [qlco]
Angiotensin Receptor [aapp, rcpt]
Type I [clas]
Targeting [ftcn]
Diseases [dsyn]
therapy [ftcn]
presently [idcn]
Insufficient [qlco]
